The immunomodulatory activity of the arabinoxylans (AXs) extracts from cereal sources has been reported to impart health benefits in terms of immune enhancement. This study investigated the effect of enzymatic extraction on extraction yield and structure of AXs from wheat flour pentosan fraction. Under the optimised conditions, the extraction yield of AXs reached up to 81.25%. Furthermore, the study determined whether water-extracted AXs (WEAXs) and enzyme-extracted AXs (E-WEAXs) from wheat flour were able to differentially stimulate nitric oxide (NO) secretion through increased levels of inducible nitric oxide synthase (iNOS) in human U937 monocytes. The results indicated that AXs concomitantly induced (P < 0.05) both NO and iNOS productions in U937 monocytes compared to untreated cells. Compared with WEAXs, E-WEAXs resulted in a higher proportion of low Mw (1-10 KDa) AXs (49.51% vs. 19.11% in WEAXs), a higher A/X ratio (0.83 vs. 0.48 in WEAXs) and a higher yield (12.83 AE 0.35% vs. 7.54 AE 0.47% in WEAXs). Moreover, E-WEAXs induced significantly (P < 0.05) greater NO and iNOS production per million viable cells (61.8 AE 2.7 lM and 42.41 AE 3.83 ng respectively) than WEAXs (51.6 AE 2.6 lM and 33.46 AE 1.48 ng, respectively). The findings suggest AXs may heighten innate immune activity in the absence of infection or disease through an iNOS-mediated stimulation of NO production. The immunomodulatory activity of the wheat-derived AXs was enhanced by enzyme treatment, with low Mw and high A/X ratio associated with elevated NO/iNOS levels in human monocytes compared to water extraction.
Introduction
Arabinoxylans (AXs) are hemicelluloses found in the outer layer and endosperm cell walls of cereal grains, such as wheat and corn (Izydorczyk & Biliaderis, 2007; Fan et al., 2016; Li et al., 2016) . It has been reported that orally administrated dietary fibre including b-glucans and AXs is able to come into contact with the mucosal immune system (Mendis et al., 2016) , in which intestinal epithelial cells together with the immune cells of the Peyer's patches play an important role in regulating immune responses (Smith et al., 2011) . Previous animal study also showed oral administration of AXs (1.6-3.2 mg day À1 ) significantly induced intestinal macrophage phagocytosis, delayed the hypersensitivity reaction and increased spleen lymphocyte proliferation (Zhou et al., 2010) . Moreover, a human study involving 80 participants showed that consumption of rice-derived AXs as a dietary supplement (3 g day À1 for 8 weeks) significantly increased interferon gamma (IFN-c) production in circulating leukocytes of healthy adults (Choi et al., 2014) , confirming immunomodulatory effects of AXs on human peripheral blood mononuclear cells. Thus, AXs may be considered a bioactive food supplement with immunity improvement properties (Zhang et al., 2015) . However, the role of AXs in certain specific immune responses, including the expression of nitric oxide (NO) synthases and downstream NO secretion, remains largely undetermined. The immune functions of NO have been found to involve antimicrobial and anti-tumour activities in vitro and in vivo (Bogdan, 2000; Lechner et al., 2005) . Inducible NO synthase (iNOS) is one isoform in a family of NOS enzymes involved in the generation of NO from L-arginine. Expression of iNOS in immune cells is induced during an immune response following stimulation by microbial polysaccharides such as lipopolysaccharides (LPS) and immune cytokines (Bogdan, 2000) . Recent studies have shown that AXs enhance NO secretion in both murine and human monocyte/macrophage cell lines (Nagata et al., 2001; Ghoneum & Matsuura, 2004) . However, the precise mechanism through which NO secretion is stimulated by AXs has not been elucidated to date.
In addition, the molecular characteristics, such as the molecular weight (Mw) and substitution degree (A/X) of cereal AXs, appear to affect their NO-inducing activities (Zhou et al., 2010; Zhang et al., 2016) . The endo-b-(1,4)-xylanases (EC 3.2.1.8) are commonly involved in cereal AXs isolation and structural modification (Zhang et al., 2014) . The yields of AX extracts using enzymatic treatment were generally low. Van Craeyveld et al. (2010) extracted 32-55% of the wheat bran AX using three different endoxylanase treatments, and Escarnot et al. (2012) tested various xylanases on the AXs extraction yield of spelt bran and hull and the highest extraction recovery was 68.8% of the total AX of raw materials. The pentosan fraction of wheat flour is a by-product of wheat starch processing, and it has been found to be an AX-enriched source that usually consists of about 12% original AXs content (Li et al., 2013) . However, there have been only limited reports of the effects of extraction and modification conditions using enzymatic treatment on the yield and molecular structures of AXs from the pentosan of wheat flour. Thus, for the first time, this study investigated whether the iNOS isoform of the NOS enzymes mediates NO production in U937 human monocytes following treatment with AXs from wheat flour. Moreover, the differential influence of the extraction method on the molecular characteristics of AXs and subsequent induction of NO/iNOS levels was investigated.
Materials and methods

Materials
A sample of dried pentosan fraction (moisture content 5.9%) was kindly provided by Henan Lianhua Monosodium Glutamate Group Co., Ltd (Xiangchen, Henan, China). Pentopan Mono BG (2500 U g À1 ), an endoxylanase product (EC 3.1.2.8, family 11 of glycosyl hydrolases) from Thermomyces lanuginosus (donor)/Aspergillus oryzae (host), was supplied by Novozyme (Bagsvaerd, Denmark). The U937 cell line was purchased from the Public Health England Culture Collections. LPS (lipopolysaccharides of Escherichia coli serotype O111:B4) was purchased from Sigma-Aldrich (Gillingham, UK). RPMI-1640 cell culture medium with L-glutamine was purchased from Lonza (Verviers, Belgium). Human iNOS (116 lg mL À1 , Code: TP311819) was purchased from Cambridge Bioscience (Cambridge, UK). The primary antibody, monoclonal iNOS antibody (4E5) (1 mg mL À1 ), was purchased from Novus Biologicals (Cambridge, UK). The secondary antibody, the rabbit anti-mouse immunoglobulins/HRP (P0260), was purchased from Dako (Glostrup, Denmark).
Extraction of AXs
The pentosan fraction of wheat flour was ground to a 0.5 mm particle size using an Ultra Centrifugal Mill ZM 200 (RETSCH Ltd. United Kingdom). Milled pentosan sample (30 g) was mixed with 200 mL of distilled water using a hand blender (800 W, WSB800U) for 45 s prior to water or enzyme extraction. For the water extraction process, the pentosanwater mixture was incubated in a shaking water bath at 40°C for 2 h followed by centrifugation (6000 g, 20 min) and collection of the supernatant (containing extracted AX). For the enzymatic extraction process, three extraction conditions (enzyme concentration, extraction time and temperature) were considered according to those previously described for endoxylanase (P-BG) in the preparation of wheat endosperm AXs (Li et al., 2013) . The effect of endoxylanase concentration (50, 100, 200, 300, 400 ppm, w/w), extraction time (2, 3, 4) and temperature (20°C, 30°C and 40°C) on extraction yield and structure of AXs from the mixed pentosan sample were determined by the enzyme extraction procedure. Following the extraction process, samples were centrifuged (6000 g, 20 min), and the supernatants were collected. Then, the supernatants (150 mL) were added to 300 lL termamyl aamylase (500 U mL À1 ) at 90°C to allow starch hydrolysis to occur. After 1 h, the solution was cooled rapidly and adjusted to pH 7. One hundred ll proteinase (1 mg mL À1 , ≥3 units mg À1 ) was added to the solution, and the mixture was incubated at 60°C for 1 h to remove unwanted protein. The sample was placed in a boiling water bath for 10 min to deactivate enzymes and then centrifuged at 6000 g for 20 min. After centrifugation, the supernatants were then precipitated according to the ethanol precipitation process described by Zhang et al. (2016) . The residue was then placed in an oven overnight at 45°C to dry and then milled using an analytical mill (IKA A11 Basic, Guangzhou, China, 50/60 Hz, 160 W).
Determination of AX extraction yields
The determination method of AXs yield was constructed using the methods described by Zhang et al. (2016) to evaluate the xylose content of the raw material and extracted AX supernatants.
Determination of monosaccharide compositions of isolated AXs
The composition assessment was performed as previously described by Zhang et al. (2016) . The mobile phase was HPLC grade water for the HPLC, and isocratic elution was achieved using a Shimadzu LC-10ADvp pump. Samples were analysed on SUPELCOGEL Pb (5 cm 9 4.6 mm) and Phenomenex ThermaSphere TS-130 columns combined with a JASCO RI-2031 refractive index (RI) detector. All analyses were conducted in triplicate.
Molecular weight distribution characterisation of extracted AXs
Size exclusion high-pressure liquid chromatography (SE-HPLC) with a RI detector (JASCO RI-2031, Jasco Corporation, Tokyo, Japan) was used to determine the Mw and size distribution of extracted AX samples using methods described by Zhang et al. (2016) . The average degree of polymerisation (avDP) was value of the apparent peak molecular mass divided by the molecular mass of anhydropentose sugars (Courtin et al., 2008) .
Cell culture
Complete cell culture medium was prepared using RPMI-1640 with L-glutamine (Luna, Belgium), 10% foetal bovine serum (FBS) and 2% penicillin-streptomycin (P/S). The human U937 monocyte cell line was grown in complete culture medium under sterile conditions in a 37°C incubator with 5% CO 2 in air atmosphere, subculturing every 2 days to maintain high cell viability (≥90%). For experimental tests, cultured U937 cells were centrifuged at 1000 g for 10 min and resuspended in RPMI-1640 medium with L-glutamine and 10% FBS such that the density of cells was set at 1 9 10 6 viable cells per mL.
Polysaccharide medium preparations
The extracted AX samples and LPS were dissolved in the RPMI-1640 medium with 5% FBS overnight at 4°C to allow the sample to become fully hydrated prior to sterile filtration through a 0.45 lm sterile filter. The LPS and solubilised AX samples were diluted in RPMI-1640 medium to yield a series of typical concentrations (1, 5, 10, 50, 500 and 1000 lg mL À1 ) (Zhang et al., 2016) for the subsequent cell culture testing. The samples were stored at 4°C prior to use.
Cell viability and growth
Cell growth and viability of U937 cells following treatment with AX samples or LPS were assessed by cell counting and trypan blue uptake. A 100 lL cell suspension at 1 9 10 6 viable cells per mL was pipetted into each well of a 96-well microplate. The AX and LPS sterile medium preparations at three high concentrations (50, 500 and 1000 lg mL À1 ) were prewarmed to 37°C, and 100 lL of each concentration was added to six replicate wells of the microplate and mixed thoroughly. After 24-h incubation (Ghoneum & Gollapudi, 2003; Zhang et al., 2016) , 40 lL from each well was mixed with 40 lL of trypan blue (Sigma-Aldrich, UK) for 1 min prior to analysis on a TC10 automated cell counter (Bio-Rad, UK). The number of blue-stained (nonviable) cells and unstained (viable) cells in each sample was counted.
NO stimulation
The NO assay was conducted as previously described by (Zhang et al., 2016) . Fifty lL of U937 cells at 1 9 10 6 viable cells per mL was added to a 96-well microplates prior to adding 50 lL of AX or LPS sample to replicate wells. Replicate untreated controls were prepared by adding 50 lL medium with 50 lL U937 cells at 1 9 10 6 viable cells per mL to wells. Background levels of nitrite and/or interference from nitrate present in AX samples were internally controlled for within the assay by taking in account the direct activity of AX samples in replicate wells containing 50 lL medium and 50 lL of diluted sterile AX sample in the absence of U937 cells. All experimental samples were evaluated in triplicate with appropriate adjustments for background nitrite/nitrate levels. The microplate was incubated (37°C, 5% CO 2 ) for 24 h before mixing 50 lL component A of the Griess' reagent to each well for 10 min at room temperature. Griess' reagent was made up with two components. Component A consisted of equal amounts by volume of 37.5 mmol L À1 sulphanilamide in deionized water and 6.5 mol L À1 HCl. Component B was 12.5 mmol L À1 N-1-napthyl ethylenediamine dihydrochloride (NEED) in deionized water. A further 50 lL component B of the Griess' reagent was added to each well, mixed well and then incubated at 4°C for 20 min. The absorbance of each well was measured at 540 nm using a microplate reader (Synergy HTX Multi-Mode Reader, Biotek, UK).
Determination of iNOS Levels
An immunoblot assay was used to determine the iNOS level in cell lysates according to previously described methodologies (Bloch et al., 1999 ). An equal volume (5 mL) of AX treatment, LPS positive control (at 50 lg mL À1 ) or untreated media control (RPMI-1640 with L-glutamine and 5% FBS) was incubated for 24 h with 5 mL cultured U937 cells set at 2.0 9 10 6 viable cells per mL. Samples were centrifuged (1000 g for 10 min) and resuspended in the fresh medium at a density of 2 9 10 6 viable cells per mL. A 9 mL aliquot of each sample was centrifuged at 1000 g for 10 min, and the supernatant discarded. The cell pellet was kept on ice, and 150 lL ice-cold lysis buffer (0.1 M Tris-HCl and 1 mM ETDA in deionized water; pH 7.8) was added to each cell pellet. The samples underwent a repeated (three times) rapid freeze/thaw process to lyse the cells by placing in a freezer (À80°C) for 15 min followed by rapid thawing in a 37°C water bath until just thawed, with vortex mixing for 10 s in between each freeze/thaw cycle. Samples were repeatedly (ten times) placed in a sonication bath (5510E-DTH, 490 W, 50/60 Hz, Bransonic, Danbury, USA) for 10 s, followed by vortex mixing in between each sonication step. The samples were centrifuged at 10 000 g for 10 min, and supernatants (cell lysates) were collected.
A 5 lL aliquot of each cell lysate was added to 500 lL ice-cold lysis buffer (1:100 dilution). Human iNOS enzyme (116 lg mL À1 ) was diluted in the iNOS standard buffer (10% glycerol, 100 mM glycine and 25 mM Tris-HCl in deionized water) to provide a set of iNOS standards at 116, 58, 29, 14.5 and 11.6 lg mL À1 . The cell lysates and iNOS standards were placed as 5 lL immunoblots on NC 45 nitrocellulose membrane (Serva Electrophoresis GmbH, Heidelberg, Germany), and 5 lL BSA solution (1 mg mL À1 BSA in deionized water) was used as a negative control (the absence of iNOS protein). The membrane was incubated in a 1:1000 dilution of monoclonal iNOS primary antibody (4E5) overnight (≤20 h) at 4°C with shaking at 60 r.p.m.
The membrane was washed five times for 5 min using TBS buffer before incubating with the rabbit anti-mouse immunoglobulins/HRP secondary antibody solution (1:1000 dilution) at room temperature for 1 h with shaking at 60 r.p.m. The membrane was washed five times for 5 min in TBS buffer, and then 1 mL chemiluminescent detection reagent (Biological Industries (BI), Lichfield, UK) was gently distributed across the membrane and left to stand for 1 min in a dark room. Images of the membrane were then captured using a G:Box (Chemi HR16, Syngene, Cambridge, UK), and Image J software (National Institute of Health, USA) was used to quantify the levels of iNOS using the iNOS standards. The iNOS level was determined from three replicate experiments.
Statistical analysis
Experiments, unless otherwise stated, were performed in triplicate and analysed by one-way ANOVA followed by a post hoc Tukey's test. A value of P < 0.05 was considered statistical significance in all cases. Data were expressed as mean AE standard error of the mean (SEM) unless stated otherwise.
Results and discussion
Extraction of AXs from the pentosan fraction of wheat flour
The original AX content of the wheat flour pentosan was determined as 15.79 AE 0.46% (dry basis). Compared with water extraction (Table 1) , the extraction yield of AXs significantly increased (P < 0.05) from 7.54% to 12.83% with increasing enzyme ) highlight significantly different AX extraction yields among the various extraction treatments (P < 0.05).
(endoxylanase, P-BG) concentration (0-400 ppm). In particular, significant increases (P < 0.05) in extraction yield positively correlated (r = 0.98) with increased enzyme concentration within the range of 50-200 ppm. Higher enzyme concentrations, from 200 ppm to 400 ppm, did not significantly increase the yield further (P > 0.05), indicating that maximum extraction condition was achieved, with no benefit in increasing the enzyme concentration any further beyond this range. The treatment temperature also showed a significant effect on the extraction yield of AXs. Temperatures of 30-40°C showed higher AX extraction yield than 20°C (P < 0.05) with an enzyme concentration of 200 ppm, a 2-h incubation and pH 4.5. Moreover, with an enzyme concentration of 400 ppm at 40°C for 2 h, recovery of AXs from the pentosan fraction reached the highest recovery level (81.25% of total AX content) identified in the study. The increased extraction yield upon enzyme treatment is likely in large part due to endoxylanases cleaving internal b-(1,4)-linkages in the xylan backbone and rendering a portion of water unextractable AXs (WUAXs) soluble and extractable (Andersson et al., 2003) . This means that a fraction of the WUAXs in the cell wall of the pentosan will be released into solution, resulting in increased extraction yield.
Monosaccharide compositions and branch degree analysis of AXs
The enzyme-extracted AXs samples (E-WEAXs) had a higher A/X ratio of 0.83 (Table S1 ) than waterextracted AXs (WEAXs) of 0.48, with A/X increasing linearly as the enzyme concentration increased from 0 to 400 ppm (R 2 = 0.958). The A/X ratio represents the degree of branching of AXs, which is an indicator of the relative proportions of the substituted xylose residues in xylan chains (Izydorczyk & Biliaderis, 2007) . The degree of substitution plays a key role in the solubility of AXs. Less arabinose substitutes resulted in a lower solubility of AXs in water (Zhang et al., 2014) , because the low A/X substitution fraction enhances aggregation of unsubstituted regions of the AXs stabilised by hydrogen bonds, which may result in an increase in viscosity or precipitation of polymer chains (Izydorczyk & Biliaderis, 2007) . Therefore, the results suggest AXs extracted from the pentosan fraction using the enzymatic treatments contained more substituted xylose residues and had a higher solubility.
Molecular characterisation of AXs
The overall Mw distribution of AXs ranged from 159 Da to 794 KDa, and it was divided into four ranges (Table S1 ). Around 79% of WEAXs were mainly in the larger Mw range of 10 KDa to 794 KDa, whereas 81-89% of E-WEAXs were in the smaller Mw range of 1 to 100 KDa. The Mw distribution curve of the E-WEAXs (Fig. 1) contains two main peaks; the major one with Mw of 12.22 KDa (log 10 Mw % 4.1, avDP = 93), and the lesser one with Mw of 3.72 KDa (log 10 Mw % 3.6, avDP = 28). However, the Mw distribution curve for the WEAX sample comprises mainly a single peak with Mw of 501.19 KDa (log 10 Mw % 5.7, avDP = 3797). In addition, the Mw distribution (Fig. 1) shows the Mw peak at around 3.72 KDa (log 10 Mw % 3.6) progressively enlarged as the concentration of enzyme increased from 50 to 400 ppm. According to previous studies, endoxylanase attacks the b-1, 4 linked D-xylopyranosyl backbone and breaks down xylan chains, thus reducing the molecular weight of AXs during enzymatic extraction (Izydorczyk & Biliaderis, 2007) . Zhang et al. (2014) showed that the Mw of AXs varies depending on the extraction and treatment methods used. Endoxylanase treatment appeared to be one of the most effective methods for modifying AXs Figure 1 The molecular weight distribution of enzyme-extracted arabinoxylans (EWEAXs) following various enzyme treatments and water-extracted arabinoxylans as a Control. [Colour figure can be viewed at wileyonlinelibrary.com] molecular structure, resulting in AXs with low Mw distribution. Furthermore, the Mw has been indicated as a crucial factor influencing the physicochemical properties in solution. Wheat AXs with low Mw exhibited less intrinsic viscosities and weak elastic properties when in solution (Izydorczyk & Biliaderis, 2007) .
Effects of AXs on the growth and viability of U937 cells
To investigate the possible relationship between the immunomodulatory activity and molecular structure of AXs, WEAX and E-WEAX with significantly different Mw distributions and monosaccharide compositions were extracted with an enzyme concentration of 400 ppm for in vitro studies.
The total cell counts of U937 macrophages treated with high concentrations of AXs (50, 500, 1000 lg mL À1 ) were not significantly different (P > 0.05) compared to the untreated control (Table 2 ). WEAX and E-WEAX did not induce a stimulatory effect on the growth of U937 cells over a period of 24 h. In addition, the viability of cells following each AX treatment was typically around 90%, which was not significantly different (P > 0.05) to untreated control cells, suggesting AX samples had no effect on U937 cell survival over a 24-h period. However, the total count of U937 cells was significantly (P < 0.05) reduced after treatment with 500 and 1000 lg mL À1 LPS compared with the untreated control ( Table 2 ). This is in concordance with previous studies indicating that LPS inhibits and blocks macrophage proliferation in a dose-dependent manner (Vairo et al., 1992; Vadiveloo et al., 1996; Muller-Decker et al., 2005) . The inhibitory effect of LPS on cell proliferation is tightly regulated through a complex network of cytokines. For example, Vadiveloo et al. (2001) found that bacterial LPS had an inhibitory effect on cell proliferation in mouse marrow-derived macrophages. They found LPS inhibited the expression of cyclin D1, which is an essential protein for proliferation in many cell types. Botanical polysaccharides extracted from plants have received considerable attention in bioscience due to their wide immunomodulatory activities and low toxicity (Schepetkin & Quinn, 2006) . Compared with LPS, this study indicated that the AX samples have no inhibitory effects on the viability and growth of human U937 macrophages, even at high concentrations of 1000 lg mL
À1
.
Effects of AXs on NO production by U937 cells NO production by U937 cells following treatment with WEAX, E-WEAX or LPS over the concentration range of 1-500 lg mL À1 was determined (Table 3 ). The LPS positive control significantly stimulated (P < 0.05) NO secretion per million viable cells at all concentrations (1-500 lg mL À1 ) compared to the untreated control. Although significant changes in NO were not detected across every single successive LPS concentration, overall the NO generated by LPS significantly (P < 0.05) increased as LPS concentration increased from 0 to 500 lg mL À1 . All concentrations of WEAX and E-WEAX tested also significantly elevated (P < 0.05) NO production by U937 cells compared with the untreated control. NO levels per million viable cells significantly increased in a dosedependent manner as the concentration of E-WEAX increased by two or more incremental concentration steps (from 1 to 10 lg mL À1 and 5 to 50 lg mL À1 ), before reaching a maximum of 61.8 AE 2.7 lM following treatment with 50 lg mL À1 E-WEAX. In contrast, NO stimulation by WEAX at the concentration range of 10-50 lg mL À1 was substantially more modest compared to that produced by similar concentrations of E-WEAX. The highest NO level produced was 53.4 lM per million viable cells after treatment with 500 lg mL À1 WEAX, but this was still significantly increased (P < 0.05) in a dose-dependent manner compared to NO levels generated by lower WEAX concentrations in the range 1-10 lg mL À1 . Thus, the optimal dose of E-WEAX for maximum NO production was found to be <500 lg mL À1 in this study, whereas The total count (910 6 cells) indicates the number of total (viable and non-viable) U937 cells after various AX treatments for 24 h. The viability (%) was calculated as the viable cell count/total cell count 9 100. The total cell count and viability after treatment with AXs or LPS were compared with the untreated control by one-way ANOVA, with the symbol * highlighting a significant difference (P < 0.05). Total cell counts are presented as mean AE standard error of six replicate samples.
WEAX probably had an optimum dose somewhere above 500 lg mL À1 . Although the peak NO secretion for the WEAX treatment may not have been reached in the assay, the findings suggest the maximum NO secretion was being approached and was substantially below that of E-WEAX. These comparisons show that there are obvious differences between E-WEAX and WEAX treatments in relation to NO stimulation, with WEAX generally having weaker NO stimulation than E-WEAX. This is consistent with the NO stimulatory activities of corn bran AXs with low and large Mw in U937 cells (Zhang et al., 2016) .
One of the main structural differences between the two types of AX samples was in the low Mw range of 1-10 KDa. The E-WEAX contained a higher portion of AX with lower avDP in this small Mw range compared with WEAX. In addition, E-WEAX presented a higher A/X ratio (0.83) compared to WEAX (0.48). Thus, the large difference in NO stimulatory activity between the two AX samples may be associated with the difference in the low 1-10 kDa Mw fractions and A/X ratio.
Effects of AX treatments on iNOS levels in U937 cells
To obtain a better understanding of AX modulation of NO production, the effect of WEAX and E-WEAX on iNOS levels was determined in human U937 monocytes. Both WEAX and E-WEAX significantly elevated iNOS levels in U937 cells (Fig. 2a) after 24 h compared with the untreated control (P < 0.05), mirroring the elevation detected in NO production. E-WEAX and WEAX resulted in a 2.5-and 2.0-fold increase in iNOS level per million viable U937 cells, respectively, compared with the untreated control (Fig. 2b) . In addition, the amount of iNOS following treatment with E-WEAX was significantly higher than with WEAX (P < 0.05). Similarly, the LPS positive control significantly increased iNOS levels compared to untreated control (P < 0.05). The stimulatory effect of AXs on iNOS was highly correlated with their stimulatory activity on NO production. Thus, the findings suggest the increased NO production by AXs is probably due, at least in part, by elevated levels of iNOS in U937 cells. This is in agreement with the previous reports that show both iNOS mRNA and protein levels in macrophages are induced by cytokines (such as IFN-c and TNF-a) and microbial polysaccharides such as LPS (Bogdan, 2000) . More recently, a study found that polysaccharides from Dendrobium officinale were able to increase iNOS expression and NO production in RAW 264.7 cells. They indicated that the stimulatory ability of D. officinale on iNOS expression was associated with the disruption of IjBa/NF-jB complexes, leading to the activation of NF-jB (Cai et al., 2015) . Thus, AXs may stimulate NO production in U937 cells through the iNOS pathway. Moreover, the immunoblots showed that E-WEAX (50 lg mL À1 ) had a higher stimulatory effect (P < 0.05) on iNOS level (42.4 AE 3.8 lg mL À1 per million viable cells) compared to the effect of WEAX (33.5 AE 1.5 lg mL
À1
per million viable cells) at the same concentration. The difference in stimulatory effect between E-WEAX and WEAX on iNOS induction overlaps with their significantly different stimulatory activity on NO production. The NO 2 À concentration (lM), presented as mean AE standard error of triplicate samples, is a measure of NO production by U937 cells. The symbol * indicates significant increase (P < 0.05) in NO secretion following AX treatment at all concentrations tested compared to the untreated control.
The symbol # indicates a significant change in NO secretion (P < 0.05) the two indicated concentrations of samples. The symbol @ indicates significant difference (P < 0.05) in NO secretion between treatment with E-WEAX and treatment with WEAX at the same concentration. The symbol $ indicates significant (P < 0.05) difference in NO secretion between E-WEAX or WEAX treatment and LPS treatment at the same concentration.
The Mw distribution of AX is considered to be a significant determinant of their immunomodulatory activity. Physicochemical properties of AXs in solution including tertiary conformation, solubility, viscosity and elastic properties depend on their molecular weight and degree of branching (Izydorczyk & Biliaderis, 2007) . For other cereal polysaccharides, such as Beta-glucan, molecular size and solubility have already been confirmed to have a substantial effect on Dectin-1 receptor activation, which is associated with immunomodulating activities of Beta-glucan such as increased level of iNOS, IL-12, TNF-a, IL-1b and IL-6 (Liu et al., 2015; Zhang et al., 2015) . Recently, wheat AX was reported to activate the Dectin-1 receptor in the HEK-Null1 Dectin-1A and B cell lines (Sahasrabudhe et al., 2016) . Therefore, it is reasonable to conclude that molecular structure, combined with these physicochemical properties of AX, may confer receptor activation that results in different stimulatory effects on iNOS expression in macrophage and subsequent NO production.
Conclusion
Dietary intervention of foods and food-derived substances with immunomodulating activities is widely studied and considered a potential way of mediating immune functions to reduce the risk of infection or cancer (Zhang et al., 2015; Mendis et al., 2016) . In this study, an enzymatic method was optimised to efficiently extract high yields (86%) of AXs with a high proportion of low MW (3.72 KDa) material and a high degree of branching (A/X = 0.83) from wheat flour pentosan. AX extracts significantly elevated NO secretion by the U937 cells compared with the untreated control (P < 0.05), suggesting the AXs have potential immunomodulation properties for improving immune function and reducing the risk of infection. Analysis of the relationship between the molecular structures and the immunomodulatory activity of AX samples suggests that enzyme-modified AXs, which have a much higher proportion of lower Mw AXs and higher A/X ratio than the nonenzyme-treated AXs, stimulate higher levels of NO production. The iNOS data suggest that stimulation of NO synthesis by AXs is closely mirrored by iNOS expression in U937 cells. This is an exciting area for future research; the findings elucidating the precise mechanisms through which the molecular structure of AXs may modulate immunomodulatory activity. Further experimental work is required to identify the AX receptor(s) on macrophages and determine their interaction with iNOS expression. candidate, Nicola Hall for their support in the experimental work.
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